These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28303296)

  • 1. Sortase A-aided Escherichia coli expression system for functional osteoprotegerin cysteine-rich domain.
    Jin M; Chen Y; Zhao Y; Che L; Ma Y; Li J; Wang Y; Tao H; Ma J; Pan B; Liu C; Huang P
    Appl Microbiol Biotechnol; 2017 Jun; 101(12):4923-4933. PubMed ID: 28303296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the interaction between osteoprotegerin and receptor activator of NF-kappaB or tumor necrosis factor-related apoptosis-inducing ligand: evidence for a pivotal role for osteoprotegerin in regulating two distinct pathways.
    Vitovski S; Phillips JS; Sayers J; Croucher PI
    J Biol Chem; 2007 Oct; 282(43):31601-9. PubMed ID: 17702740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of human RANKL complexed with its decoy receptor osteoprotegerin.
    Luan X; Lu Q; Jiang Y; Zhang S; Wang Q; Yuan H; Zhao W; Wang J; Wang X
    J Immunol; 2012 Jul; 189(1):245-52. PubMed ID: 22664871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cloning and expression of the novel antimicrobial target enzyme Sortase gene in two prokaryotic vectors].
    Luo L; Jiang B; Chen M
    Wei Sheng Wu Xue Bao; 2009 Feb; 49(2):186-90. PubMed ID: 19445173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoprotegerin decreases human osteoclast apoptosis by inhibiting the TRAIL pathway.
    Chamoux E; Houde N; L'Eriger K; Roux S
    J Cell Physiol; 2008 Aug; 216(2):536-42. PubMed ID: 18338379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infantile haemangioma expresses tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptors, osteoprotegerin and receptor activator for nuclear factor кB ligand (RANKL).
    Vishvanath A; Itinteang T; Tan ST; Day DJ
    Histopathology; 2011 Sep; 59(3):397-406. PubMed ID: 22034880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.
    Van Poznak C; Cross SS; Saggese M; Hudis C; Panageas KS; Norton L; Coleman RE; Holen I
    J Clin Pathol; 2006 Jan; 59(1):56-63. PubMed ID: 16394281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma.
    Lamoureux F; Picarda G; Garrigue-Antar L; Baud'huin M; Trichet V; Vidal A; Miot-Noirault E; Pitard B; Heymann D; Rédini F
    Cancer Res; 2009 Jan; 69(2):526-36. PubMed ID: 19147566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Homologous analysis of Streptococcus suis srt gene and prokaryotic expression of srtA].
    Dong YQ; Wang CJ; Zheng F; Pan XZ; Fan HJ; Tang JQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 May; 23(5):399-401. PubMed ID: 17488596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function.
    McGonigle JS; Giachelli CM; Scatena M
    Angiogenesis; 2009; 12(1):35-46. PubMed ID: 19105036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Osteoprotegerin and Its Ligands in Vascular Function.
    Rochette L; Meloux A; Rigal E; Zeller M; Cottin Y; Vergely C
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-in-one chromatography-free purification, tag removal, and site-specific modification of recombinant fusion proteins using sortase A and elastin-like polypeptides.
    Bellucci JJ; Amiram M; Bhattacharyya J; McCafferty D; Chilkoti A
    Angew Chem Int Ed Engl; 2013 Mar; 52(13):3703-8. PubMed ID: 23424160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin: multiple partners for multiple functions.
    Baud'huin M; Duplomb L; Teletchea S; Lamoureux F; Ruiz-Velasco C; Maillasson M; Redini F; Heymann MF; Heymann D
    Cytokine Growth Factor Rev; 2013 Oct; 24(5):401-9. PubMed ID: 23827649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies.
    Higgs JT; Jarboe JS; Lee JH; Chanda D; Lee CM; Deivanayagam C; Ponnazhagan S
    Mol Cancer Res; 2015 May; 13(5):819-27. PubMed ID: 25636966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sortase A-Mediated Metabolic Enzyme Ligation in Escherichia coli.
    Matsumoto T; Furuta K; Tanaka T; Kondo A
    ACS Synth Biol; 2016 Nov; 5(11):1284-1289. PubMed ID: 27700053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.
    Liu XH; Kirschenbaum A; Yao S; Levine AC
    Endocrinology; 2005 Apr; 146(4):1991-8. PubMed ID: 15618359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells.
    Kats A; Norgård M; Wondimu Z; Koro C; Concha Quezada H; Andersson G; Yucel-Lindberg T
    J Cell Mol Med; 2016 Jun; 20(6):1128-38. PubMed ID: 26987561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoprotegerin (OPG) binds with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL): suppression of TRAIL-induced apoptosis in ameloblastomas.
    Sandra F; Hendarmin L; Nakamura S
    Oral Oncol; 2006 Apr; 42(4):415-20. PubMed ID: 16413220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new vector coupling ligation-independent cloning with sortase a fusion for efficient cloning and one-step purification of tag-free recombinant proteins.
    Jia X; Crawford T; Zhang AH; Mobli M
    Protein Expr Purif; 2019 Sep; 161():1-7. PubMed ID: 31022449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of osteoprotegerin in combination with interleukin-6 on inhibition of osteoclast differentiation.
    Wang X; Luo Y; Liao WB; Zhang J; Chen TM
    Chin J Traumatol; 2013; 16(5):277-80. PubMed ID: 24103822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.